Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in ErbB2 Over-Expressing Advanced or Metastatic Breast Cancer
NCT00320411Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00320411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320411.